RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus
![Federica DI NICOLANTONIO | Professor (Associate) | PhD | Università degli Studi di Torino, Turin | UNITO | Dipartimento di Oncologia Federica DI NICOLANTONIO | Professor (Associate) | PhD | Università degli Studi di Torino, Turin | UNITO | Dipartimento di Oncologia](https://i1.rgstatic.net/ii/profile.image/715054546710534-1547493697609_Q512/Federica-Di-Nicolantonio.jpg)
Federica DI NICOLANTONIO | Professor (Associate) | PhD | Università degli Studi di Torino, Turin | UNITO | Dipartimento di Oncologia
![Injected Vitamin C Boosts Power of Cancer Immunotherapy in Mice | American Association for the Advancement of Science Injected Vitamin C Boosts Power of Cancer Immunotherapy in Mice | American Association for the Advancement of Science](https://i.ytimg.com/vi/kR6HgJ7GSLI/maxresdefault.jpg)
Injected Vitamin C Boosts Power of Cancer Immunotherapy in Mice | American Association for the Advancement of Science
Lacort Medical - 🚨FREE REGISTRATION www.islbcongress.org OCT 22nd 2021 Don't miss this TRACK! Translational Research in Liquid Biopsy Dr Lynette M. Sholl🇺🇸 Dr Philip Mack🇺🇸 Dr Nicola Aceto🇨🇭 Dr Miguel A. Molina-Vila🇪🇸
![Federica DI NICOLANTONIO | Professor (Associate) | PhD | Università degli Studi di Torino, Turin | UNITO | Dipartimento di Oncologia Federica DI NICOLANTONIO | Professor (Associate) | PhD | Università degli Studi di Torino, Turin | UNITO | Dipartimento di Oncologia](https://www.researchgate.net/profile/Federica-Di-Nicolantonio/publication/304154084/figure/fig1/AS:375353844486144@1466502738256/figure-fig1_Q320.jpg)
Federica DI NICOLANTONIO | Professor (Associate) | PhD | Università degli Studi di Torino, Turin | UNITO | Dipartimento di Oncologia
![Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers | Nature Communications Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncomms9305/MediaObjects/41467_2015_Article_BFncomms9305_Fig1_HTML.jpg)